5% KOH Solution vs. Placebo and Diclofenac Gel for the Treatment of Actinic Keratosis
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Actinic Keratosis
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04552327
- Collaborators
- Gesellschaft für Therapieforschung mbH
- Investigators
- Study Director: Uwe Reinhold, Prof. MVZ - Dermatologisches Zentrum Bonn GmbH